chr3-39112462-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001366900.1(TTC21A):āc.440A>Gā(p.Tyr147Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000607 in 1,613,920 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001366900.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TTC21A | NM_001366900.1 | c.440A>G | p.Tyr147Cys | missense_variant | 5/29 | ENST00000683103.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TTC21A | ENST00000683103.1 | c.440A>G | p.Tyr147Cys | missense_variant | 5/29 | NM_001366900.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000224 AC: 34AN: 152096Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000100 AC: 25AN: 249346Hom.: 0 AF XY: 0.000133 AC XY: 18AN XY: 135304
GnomAD4 exome AF: 0.0000438 AC: 64AN: 1461824Hom.: 0 Cov.: 31 AF XY: 0.0000550 AC XY: 40AN XY: 727216
GnomAD4 genome AF: 0.000224 AC: 34AN: 152096Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74296
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2023 | The c.440A>G (p.Y147C) alteration is located in exon 5 (coding exon 5) of the TTC21A gene. This alteration results from a A to G substitution at nucleotide position 440, causing the tyrosine (Y) at amino acid position 147 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at